Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

NCT00351923 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles
Mumps
Rubella
Varicella

Interventions

BIOLOGICAL: MeMuRu-OKA (study vaccine)

Sponsor

GlaxoSmithKline